Omvoh 100 mg solution for injection in pre-filled pen

DRUG2 trials

Sponsors

Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif, Eli Lilly & Co.

Conditions

Crohn's Diseaseseverely active ulcerative colitis (US) and CD (Crohn’s disease)

Phase 4

Efficacy of MIrikizumab to achieve traNsmural healing in patiENTs with Crohn’s Disease : EMINENT CD

Not yet recruitingCTIS2025-521889-95-00

Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube DigestifCrohn's Disease

Target: 110Updated: 2026-02-05

A Study to Evaluate Mirikizumab Concentrations in Breast Milk Following Administration of Mirikizumab by Subcutaneous Injection in Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

Not yet recruitingCTIS2025-522362-78-00

Eli Lilly & Co.severely active ulcerative colitis (US) and CD (Crohn’s disease)

Target: 12Updated: 2026-04-28